🇺🇸 FDA
Company

Krystal

Krystal Biotech

KRYS biotech USA

Quick answer

Krystal is a biotech company (KRYS) headquartered in PITTSBURGH, PA, USA with 14 tracked pipeline programs.

Pipeline (14)

project

KB803

Dystrophic Epidermolysis Bullosa

Phase 3 · mab · active

1 trials project

Open Label Topical Beremagene Geperpavec (B-VEC)

Dystrophic Epidermolysis Bullosa

Phase 3 · mab · completed

1 trials project

Topical Beremagene Geperpavec

Dystrophic Epidermolysis Bullosa

Phase 3 · mab · completed

2 trials project

KB105

Autosomal Recessive Ichthyosis

Phase 2 · mab · active

1 trials project

KB105

TGM-1 Related Autosomal Recessive Congenital Ichthyosis

Phase 2 · mab · active

1 trials project

KB304

Wrinkles in Decolletage

Phase 2 · mab · active

1 trials project

KB707

Cancer

Phase 2 · mab · active

1 trials project

KB707

Lung Cancer, Non-small Cell

Phase 2 · mab · active

1 trials project

KB801

Neurotrophic Keratitis

Phase 2 · mab · active

1 trials project

Mebendazole

Pilomyxoid Astrocytoma

Phase 2 · small_molecule · completed

1 trials project

KB301

Skin Roughness

Phase 1 · mab · active

1 trials project

KB407 (Nebulization)

Cystic Fibrosis

Phase 1 · mab · active

2 trials project

KB408 (Nebulization)

Alpha 1-Antitrypsin Deficiency

Phase 1 · small_molecule · active

1 trials project

LY2456302

Anxiety Disorders

Phase 1 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12364775

Viral vectors for cancer therapy

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12128122

Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic

Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11918660

Viral vectors for cancer therapy

Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11865148

Methods of delivering transgenes to the eye

Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11779660

Viral vectors for cancer therapy

Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11717547

Compositions and methods for the treatment of autosomal recessive congenital ich

Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11642384

Compositions and methods for the treatment of Netherton Syndrome

Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11185564

Compositions and methods for the treatment of wounds, disorders, and diseases of

Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)